Danaher 

€161.95
0
-€2.95-1.79% Friday 19:55

Statistics

Day High
165.45
Day Low
161.55
52W High
206.6
52W Low
155.46
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21AprExpected
Q4 2025
Next
1.65
1.72
1.79
1.86
Expected EPS
1.6529634784
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DAP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific competes directly with Danaher in the life sciences and diagnostics sectors, offering similar products and services.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, through its acquisition of Allergan, competes in the biopharmaceuticals sector, overlapping with Danaher's life sciences division.
GE Aerospace
GE
Mkt Cap296.57B
General Electric's healthcare division competes with Danaher in medical diagnostics and research products.
Becton Dickinson
BDX
Mkt Cap55.98B
Becton, Dickinson and Company offers a range of medical devices and laboratory equipment, competing with Danaher's life sciences and diagnostics segments.
Resmed
RMD
Mkt Cap32.71B
ResMed competes in the medical devices sector, particularly in products for sleep disorders, overlapping with Danaher's respiratory and sleep business.
Stryker
SYK
Mkt Cap126.97B
Stryker operates in the medical technology field, offering products that compete with Danaher's medical and dental products.
Danaher
DHR
Mkt Cap135.26B
Danaher competes with itself through its diverse portfolio of subsidiaries, each operating in similar sectors as its competitors.
Mettler-Toledo International
MTD
Mkt Cap25.61B
Mettler-Toledo International competes in the precision instruments sector, offering products that overlap with Danaher's analytical and diagnostic solutions.
Agilent Technologies
A
Mkt Cap32.66B
Agilent Technologies competes with Danaher in the life sciences, diagnostics, and applied chemical markets, offering similar analytical instruments and services.

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Show more...
CEO
Mr. Steven M. Rales
Employees
78000
Country
USA
ISIN
US2358511028

Listings

0 Comments

Share your thoughts

FAQ

What is Danaher stock price today?
The current price of DAP.STU is €161.95 EUR — it has decreased by -1.79% in the past 24 hours. Watch Danaher stock price performance more closely on the chart.
What is Danaher stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Danaher stocks are traded under the ticker DAP.STU.
Is Danaher stock price growing?
DAP.STU stock has fallen by -2.1% compared to the previous week, the month change is a -3.73% fall, over the last year Danaher has showed a -2.91% decrease.
When is the next Danaher earnings date?
Danaher is going to release the next earnings report on April 21, 2026.
What were Danaher earnings last quarter?
DAP.STU earnings for the last quarter are 1.86 EUR per share, whereas the estimation was 1.81 EUR resulting in a +3.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Danaher have?
As of April 11, 2026, the company has 78,000 employees.
In which sector is Danaher located?
Danaher operates in the Healthcare sector.
When did Danaher complete a stock split?
Danaher has not had any recent stock splits.
Where is Danaher headquartered?
Danaher is headquartered in Washington, USA.